Summary: A single exposure to a widely used fungicide during pregnancy produced health effects that persisted through twenty generations in an experimental mammal model, according to a new Washington State University study. The research found inherited conditions—including kidney, prostate and reproductive disorders—that not only persisted but intensified many generations after the original exposure.
By the 15th generation the inherited pathology became lethal in many lineages, with increased deaths during labor affecting both mothers and offspring. These results, described as epigenetic transgenerational inheritance, suggest that some present-day chronic diseases may trace back to environmental exposures experienced by distant ancestors.
Key Facts
- Twenty-generation persistence: Disease risk produced by a single ancestral toxic exposure remained detectable for at least twenty generations, equivalent to roughly 500 years in human terms.
- Lethal progression later: Disease incidence was relatively stable for the first 14 generations, then increased dramatically around generation 15 and beyond, producing severe abnormalities and increased mortality during birth.
- Germline programming: Alterations that occur in sperm or egg cells (the germline) can become stable and persist across generations in a way similar to genetic mutations.
- Conservative dosing: The experiment used a vinclozolin dose scaled conservatively—below what an average person might consume in a typical diet—to test germline sensitivity to environmental chemicals.
- Preventative potential: Researchers have identified epigenetic biomarkers that can indicate susceptibility to certain diseases decades before clinical onset, opening possibilities for preventative interventions.
Source: Washington State University
A single prenatal exposure to a toxic fungicide raised disease risk for twenty subsequent generations, with inherited health problems worsening many generations after the original exposure.
These findings come from a Washington State University study using rats to examine how environmental exposures can be transmitted across generations through changes to reproductive cells. The research, published in the Proceedings of the National Academy of Sciences, was led by WSU biologist Michael K. Skinner, a long-time investigator of epigenetic transgenerational inheritance.
Skinner and colleagues say the study has implications for understanding rising rates of chronic disease in humans. The results support the idea that exposures experienced by ancestors—decades or centuries earlier—can influence current disease risk. At the same time, epigenetic research points to measurable biomarkers that could enable early detection and prevention.
“This study really does say that this is not going to go away,” Skinner commented. “We need to do something about it. We can use epigenetics to move us away from reactionary medicine and toward preventative medicine.”
Skinner first reported epigenetic inheritance of disease in 2005 and has since published many studies. The mechanism involves altered DNA methylation and other epigenetic marks in sperm and egg cells. Once these marks are established in the germline, they can persist across generations and influence disease risk in descendants.
Earlier work from the same group examined ten generations of rats after ancestral exposure to vinclozolin, a fungicide primarily used on fruit crops to control blight, mold and rot. That study documented persistent increases in disease incidence across multiple organ systems. The current paper extends the observation to twenty generations and reports similar chronic disease patterns in kidneys, prostate, testes and ovaries, along with new and severe parturition (birth) abnormalities appearing in later generations.
“The presence of disease was relatively constant early on,” Skinner explained, “but around the 15th generation we began to see an escalation. By the 16th through 18th generations the pathology became prominent and included maternal deaths during labor and stillbirths—an alarming outcome.”
The research team intentionally used a conservative exposure level to demonstrate that even low-dose ancestral exposure can produce stable, long-term germline effects. Co-authors on the paper include Eric E. Nilsson, lead author Alexandra A. Korolenko, and Sarah De Santos.
Skinner suggests that epigenetic inheritance could account for part of the documented increase in chronic diseases in human populations that parallels the growth in pesticide and chemical use. Today, a majority of Americans live with at least one chronic condition and many have multiple diagnoses, trends that may reflect both contemporary exposures and long-term inherited susceptibilities.
Importantly, the field has begun to produce epigenetic biomarkers in humans that correspond to the animal findings. These biomarkers can indicate increased susceptibility long before disease manifests, enabling targeted prevention strategies. “In humans we already have epigenetic biomarkers for roughly ten different disease susceptibilities,” Skinner noted. “They don’t diagnose current disease; they indicate elevated risk in the future, allowing preventative measures to be taken.”
Key Questions Answered:
A: No. The study indicates baseline risk may be elevated because of ancestral exposures, but that is not a fixed destiny. Epigenetic biomarkers can identify susceptibilities decades in advance, allowing preventative strategies that reduce risk before disease develops.
A: The study’s authors describe a possible tipping-point effect: epigenetic changes can accumulate or interact across generations, leading to increased cellular stress and a sudden emergence of more severe pathologies. In the rat model, this presented as lethal birth complications in later generations.
A: The researchers used vinclozolin, a fungicide commonly applied to fruit crops. The dose was conservatively scaled to be below typical human dietary exposure levels, demonstrating germline sensitivity to relatively low toxin levels.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full by the editorial team.
- Additional context and explanation were provided by staff to clarify implications for human health.
About this epigenetics research news
Author: Shawn Vestal
Source: Washington State University
Contact: Shawn Vestal – Washington State University
Image: Image credited to Neuroscience News
Original Research: Closed access. “Stability of epigenetic transgenerational inheritance of adult-onset disease and parturition abnormalities” by Alexandra A. Korolenko, Eric E. Nilsson, Sarah De Santos, and Michael K. Skinner. PNAS. DOI: 10.1073/pnas.2523071123
Abstract
Stability of epigenetic transgenerational inheritance of adult-onset disease and parturition abnormalities
Previous work studied epigenetic transgenerational inheritance through ten generations in a mammalian model and demonstrated both stability of inheritance and a generational increase in disease incidence. Building on that research, the present study tracked the same rat lineage with ancestral vinclozolin exposure across twenty generations.
Findings show persistent, stable transmission of epigenetic alterations, evidenced by increasing numbers of differentially methylated DNA regions across multiple generations. Tests for apoptosis revealed elevated germline cell death in male rats from both maternal and paternal lineages, suggesting epigenetic disruption of spermatogenesis.
After sixteen generations, ancestrally exposed lineages displayed significant parturition abnormalities in both maternal and paternal lines, including maternal mortality during labor and stillbirths. Pathological assessments also revealed abnormalities across multiple tissue types and a higher overall incidence of disease.
These observations establish the generational stability of epigenetic inheritance over twenty generations in a mammalian system while highlighting the emergence of new, severe pathologies in later generations. The results carry implications for human health concerning ancestral environmental exposures, reproductive disorders and long-term disease susceptibility.